Elham Khanafshar, M.D.

Pathologist

Clinics

More about Elham Khanafshar

Additional Languages

Farsi

Education

Tehran University of Medical Science 1997

Residencies

Cedars-Sinai Medical Center 2003

Fellowships

UCSD Medical Center 2004
University of Southern California 2005

Selected Research and Publications

1. Spassov DS, Wong CH, Harris G, McDonough S, Phojanakong P, Wang D, Hann B, Bazarov AV, Yaswen P, Khanafshar E, Moasser MM. A tumor-suppressing function in the epithelial adhesion protein Trask. Oncogene. 2012 Jan 26; 31(4):419-31.
2. Guerrero MA, Lindsay S, Suh I, Vriens MR, Khanafshar E, Shen WT, Gosnell J, Kebebew E, Duh QY, Clark OH. Medullary Thyroid Cancer: It is a pain in the neck? J Cancer. 2011; 2:200-5.
3. Mathur A, Moses W, Rahbari R, Khanafshar E, Duh QY, Clark O, Kebebew E. Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer. 2011 Oct 1; 117(19):4390-5.
4. Moalem J, Choi DX, Khanafshar E, Ruan DT, Woeber KA, Clark OH, Kebebew E. Metastatic papillary thyroid cancer misdiagnosed as non-small [corrected] cell lung cancer. Thyroid. 2011 Mar; 21(3):319-23.
5. Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011 Mar; 5(1):51-6.
6. Khanafshar E, Lloyd RV. The spectrum of papillary thyroid carcinoma variants. Adv Anat Pathol. 2011 Jan; 18(1):90-7.
7. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011 Mar; 21(3):243-51.
8. Mathur A, Weng J, Moses W, Steinberg SM, Rahbari R, Rahabari R, Kitano M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E. A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. Surgery. 2010 Dec; 148(6):1170-6; discussion 1176-7.
9. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E. Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol. 2011 Apr; 18(4):1158-65.
10. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg. 2010 Nov; 34(11):2589-94.
11. Meyer-Rochow GY, Jackson NE, Conaglen JV, Whittle DE, Kunnimalaiyaan M, Chen H, Westin G, Sandgren J, Stålberg P, Khanafshar E, Shibru D, Duh QY, Clark OH, Kebebew E, Gill AJ, Clifton-Bligh R, Robinson BG, Benn DE, Sidhu SB. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer. 2010 Sep; 17(3):835-46.
12. Guerrero MA, Vriens MR, Suh I, Khanafshar E, Clark OH. Intraoperative diagnostic strategy to distinguish parathyroid adenomas from metastatic thyroid cancer. Endocr Pract. 2009 Jul-Aug; 15(5):454-7.
13. Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010 May 15; 160(2):179-83.
14. Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH. Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer. 2009 Jan 15; 115(2):334-44.
15. Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers. Surgery. 2008 Dec; 144(6):908-13; discussion 913-4.
16. Shibru D, Hwang J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? Cancer. 2008 Sep 1; 113(5):930-5.
17. Fernandez-Ranvier GG, Weng J, Yeh RF, Khanafshar E, Suh I, Barker C, Duh QY, Clark OH, Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg. 2008 Sep; 143(9):841-6; discussion 846.
18. Sippel RS, Elaraj DM, Khanafshar E, Zarnegar R, Kebebew E, Duh QY, Clark OH. Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid. World J Surg. 2008 May; 32(5):702-7.
19. Fernandez-Ranvier GG, Jensen K, Khanafshar E, Quivey JM, Glastonbury C, Kebebew E, Duh QY, Clark OH. Nonfunctioning parathyroid carcinoma: case report and review of literature. Endocr Pract. 2007 Nov-Dec; 13(7):750-7.
20. Sippel RS, Elaraj DM, Khanafshar E, Kebebew E, Duh QY, Clark OH. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid? Surgery. 2007 Dec; 142(6):851-7; discussion 857.e1-2.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.